Togo vs United States of America: Prevalence rate of hypertension in men aged 30-79
Togo
34.3
in 2019
United States of America
34.1
in 2019
Togo rank
136th
United States of America rank
139th
Prevalence rate of hypertension in men aged 30-79 over time
- Togo
- United States of America
How they compare
Togo currently reports 34.3 against 34.1 in United States of America, a difference of 0.2.
Across all 30 years both countries report, Togo has been ahead every year.
Togo ranks 136th and United States of America ranks 139th of 195 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Togo | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 35.82 | 32.85 | 2.97 | Togo |
| 2000s | 36.92 | 33.27 | 3.65 | Togo |
| 2010s | 35.6 | 33.81 | 1.79 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Togo or United States of America?
- Togo, at 34.3 against 34.1 in United States of America as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Togo and United States of America?
- 0.2, with Togo ahead.
- How many years of comparable data are there for Togo and United States of America?
- 30 years are reported by both, from 1990 to 2019.
- How do Togo and United States of America rank globally for prevalence rate of hypertension in men aged 30-79?
- Togo ranks 136th and United States of America ranks 139th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.